the aid library

LIST OPTIONS

Filter

10838

Sort by:

Direction:

Download (327)

View PDF (748)

Water sanitation and hygiene for accelerating and sustaining progress on neglected tropical diseases: A global strategy 2015-2020

World Health Organization (WHO) (2015) C_WHO

Water, sanitation and hygiene (WASH) are critical in the prevention and care for all of the 17 neglected tropical diseases (NTDs) scheduled for intensified control or elimination by 2020.
Provision of safe water, sanitation and hygiene is one of the five key interventions within the global NTD ... more

Download (146)

View PDF (185)

Keeping the vector out: housing improvements for vector control and sustainable development

Kraef, C.; Röbbel, N. World Health Organization WHO (2017) C_WHO

Vector-borne diseases are responsible for 17% of the global burden of communicable diseases and more than 500 000 deaths annually. The ambitious global targets for the control of vector-borne diseases come in the context of the (re-)emergence of diseases, increasing resistances to insecticides and u... more

Download (29)

View PDF (29)

Fact Sheet Hypertension

World Health Organization (WHO) World Health Organization (WHO) (2023) C_WHO

The World Health Organization's fact sheet on hypertension provides a comprehensive overview of high blood pressure, highlighting its prevalence, risk factors, and health implications. It emphasizes that hypertension is a major cause of premature death worldwide, with an estimated 1.28 billion adult... more

Download (21)

View PDF (26)

Alcohol use

Institute for Health Metrics and Evaluation (2024) CC

The IHME webpage discusses alcohol use as a significant global health risk, responsible for over 1.8 million deaths annually. It highlights age-related differences in alcohol's health impacts, with no benefits for individuals aged 15–39 and potential small benefits for those aged 40 and above unde... more

Download (18)

View PDF (21)

Physical Activity and Chronic Disease Prevention

Missouri Consolidated Health Care Plan YouTube (2021) CC

The video titled "Physical Activity and Chronic Disease Prevention" emphasizes the importance of regular physical activity in reducing the risk of chronic diseases. It discusses how engaging in consistent exercise can help prevent conditions such as heart disease, diabetes, and certain cancers. The ... more

Download (26)

View PDF (25)

How dietary factors influence disease risk

National Institutes of Health (NIH) National Institutes of Health (NIH) (2017) CC

The NIH webpage discusses how dietary habits influence the risk of heart disease, stroke, and type 2 diabetes. It highlights that both excessive and insufficient intake of certain foods and nutrients can increase mortality risk from these conditions, emphasizing the importance of a balanced diet for... more

Download (59)

View PDF (32)

Noncommunicable Diseases Fact Sheet

Pan American Health Organization PAHO (2024) C_WHO

Chronic noncommunicable diseases (NCDs) are the number one cause of death and disability in the world. The term NCDs refers to a group of conditions that are not mainly caused by an acute infection, result in long-term health consequences and often create a need for long-term treatment and care. The... more

Download (44)

View PDF (32)

Palliative care: Models of service delivery and symptom management

World Health Organization WHO (2024) C_WHO

This course aims to provide information on the basic understanding of palliative care and the elements of service program for delivering palliative care. The course contents will also include the considerations in managing signs, symptoms and assessing the patient as well as communicating with the p... more

Download (54)

View PDF (34)

Enfermedades no transmisibles - Las enfermedades crónicas, no transmisibles (ENT) son la principal causa de muerte y discapacidad en el mundo

Pan American Health Organization PAHO (2024) C_WHO

Download (40)

View PDF (53)

Guidelines for Management of ST-Elevated Myocardial Infarction

Directorate General of Health Services Ministry of Health & Family Welfare Government of India (2022) CC

Myocardial infarctions are generally clinically classified into ST elevation MI (STEMI) and non-ST elevation MI (NSTEMI), based on changes in ECG. When blood flow to a part of the heart stops or the heart is injured and fails to receive enough oxygen required for its adequate functioning the conditi... more

Download (107)

View PDF (96)

Quantifying alcohol’s harm to others: a research and policy proposal

World Health Organisation (WHO) (2024) CC

Just under 2.5 million people die annually due to alcohol use. This global estimate, however, excludes most of the health burden borne by others than the alcohol user. Alcohol’s harm to others includes a multitude of conditions, such as trauma from traffic crashes, fetal disorders due to prenatal... more

Download (231)

View PDF (210)

Obstetric Fistula Strategic Plan 2022 - 2026

Government of Zambia World Health Organisation (WHO) Regional Office Africa (2023) C_WHO

Globally, over two million women live with obstetric fistula with the majority of the cases being from Africa. In low-resource settings such as Zambia, obstetric fistula (OF) is a visible indicator of gaps in maternal health care resulting in failure to provide adequate, accessible and quality m... more

Download (274)

View PDF (370)

Therapeutics and COVID-19 (Living Guideline, 10 November 2023)

World Health Organization WHO (2023) C_WHO

WHO has updated its guidelines for COVID-19 therapeutics, with revised recommendations for patients with non-severe COVID-19. This is the 13th update to these guidelines. Updated risk rates for hospital admission in patients with non-severe COVID-19 The guidance includes updated risk rates for... hospital admission in patients with non-severe COVID-19. The current COVID-19 virus variants tend to cause less severe disease while immunity levels are higher due to vaccination, leading to lower risks of severe illness and death for most patients. This update includes new baseline risk estimates for hospital admission in patients with non-severe COVID-19. The new ‘moderate risk’ category now includes people previously considered to be high risk including older people and/or those with chronic conditions, disabilities, and comorbidities of chronic disease. The updated risk estimates will assist healthcare professionals to identify individuals at high, moderate or low risk of hospital admission, and to tailor treatment according to WHO guidelines: **High: **People who are immunosuppressed remain at higher risk if they contract COVID-19, with an estimated hospitalization rate of 6%. **Moderate: **People over 65 years old, those with conditions like obesity, diabetes and/or chronic conditions including chronic obstructive pulmonary disease, kidney or liver disease, cancer, people with disabilities and those with comorbidities of chronic disease are at moderate risk, with an estimated hospitalization rate of 3%. Low: Those who are not in the high or moderate risk categories are at low risk of hospitalization (0.5%). Most people are low risk. Review of COVID-19 treatments for people with non-severe COVID-19 WHO continues to strongly recommend nirmatrelvir-ritonavir (also known by its brand name ‘Paxlovid’) for people at high-risk and moderate risk of hospitalization. The recommendations state that nirmatrelvir-ritonavir is considered the best choice for most eligible patients, given its therapeutic benefits, ease of administration and fewer concerns about potential harms. Nirmatrelvir-ritonavir was first recommended by WHO in April 2022. If nirmatrelvir-ritonavir is not available to patients at high-risk of hospitalization, WHO suggests the use of molnupiravir or remdesivir instead. WHO suggests against the use of molnupiravir and remdesivir for patients at moderate risk, judging the potential harms to outweigh the limited benefits in patients at moderate risk of hospital admission. For people at low risk of hospitalization, WHO does not recommend any antiviral therapy. Symptoms like fever and pain can continue to be managed with analgesics like paracetamol. WHO also recommends against use of a new antiviral (VV116) for patients, except in clinical trials. The update also includes a strong recommendation against the use of ivermectin for patients with non-severe COVID-19. WHO continues to advise that in patients with severe or critical COVID-19, ivermectin should only be used in clinical trials. more

Download (145)

View PDF (129)

Promoting physical activity for older people: a toolkit for action

World Health Organisation (WHO) (2023) C_WHO

This ACTIVE toolkit provides evidence-based guidance on the key approaches to promote and enable older people to be physically active, regardless of who they are, where they live, or their intrinsic capacities (for example their visual or cognitive abilities) or whether they live with chronic condit... more

Download (142)

View PDF (135)

Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP)

World Health Organisation (WHO) (2023) C_WHO

Le manuel de formation Guide d’intervention humanitaire mhGAP (GIH-mhGAP), est conçu pour guider les animateurs dans la formation des prestataires de soins de santé non spécialisés à la gestion des troubles mentaux, neurologiques et liés à la consommation de substances dans les situations d... more

Download (116)

View PDF (144)

Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP)

World Health Organisation (WHO) (2023) C_WHO

Download (92)

View PDF (112)

Formation des prestataires de soins de santé au Guide d’intervention humanitaire mhGAP(GIH-mhGAP)

World Health Organisation (WHO) (2023) C_WHO

Download (112)

View PDF (163)

Géohelminthiases - Principaux faits

World Health Organization WHO (2023) CC

Les géohelminthiases comptent parmi les infections les plus courantes dans le monde, plus de 1,5 milliard de personnes, soit près de 24 % de la population mondiale, étant infestées à l’échelle mondiale. Ces infections touchent les communautés les plus pauvres et les plus défavorisées ayan... more

Download (88)

View PDF (366)

Cystic Echinococcosis (CE)

Global Health; Division of Parasitic Diseases and Malaria (2020) CC

People who accidentally swallow the eggs of the Echinococcus granulosus tapeworm are at risk for infection. Dogs that eat home-slaughtered sheep and other livestock become infected with the tapeworm Echinococcus granulosus and the tapeworm eggs can be found in their stool. Direct contact with infect... more

Download (186)

View PDF (246)

Stratégie de riposte face à la résistance aux antipaludiques en Afrique

World Health Organisation (WHO) (2023) C_WHO

La Stratégie de riposte face à la résistance aux antipaludiques en Afrique est un document technique de sensibilisation qui se fonde sur les bases factuelles les plus solides dont on dispose et vise à réduire au maximum la menace et l’impact de la résistance aux antipaludiques de Plasmodium ... more